Chen X, Yang Y, Berger I, Khalid U, Patel A, Cai J, Farwell MD, Langer C, Aggarwal C, Albelda SM, Katz SI: Early detection of pemetrexed-induced inhibition of thymidylate synthase in non-small cell lung cancer with FLT-PET imaging. Oncotarget Page: [Epub ahead of print] Sep 2016.
Lameka K, Farwell MD, Ichise M: Positron Emission Tomography. Handb Clin Neurol. 135: 209-227, 2016.
Mankoff DA, Edmonds CE, Farwell MD, Pryma DA: Development of Companion Diagnostics. Semin Nucl Med. 46(1): 47-56, 2016.
Shah NN, Torigian DA, Farwell MD, Hwang WT, Frey NV, Nasta S, Landsburg DJ, Mato AR, June CH, Schuster SJ, Porter DL, Svoboda J: Utility of FDG-PET/CT in lymphoma patients undergoing immunotherapy with autologous CTL019 T-cells. J Clin Oncol. ASCO annual meeting, 2015.
Mankoff DA, Farwell MD, Clark AS, Pryma DA: How imaging can impact clinical trial design: molecular imaging as a biomarker for targeted cancer therapy. Cancer J. 21(3): 218-224, 2015.
Farwell MD, Clark AS, Mankoff DA: How imaging biomarkers can inform clinical trials and clinical practice in the era of targeted cancer therapy. JAMA Oncology 1(4): 421-422, 2015.
Farwell MD, Pryma DA, Mankoff DA: PET/CT imaging in cancer: Current applications and future directions. Cancer 120(22): 3433-3445, 2014.
Harris PE, Farwell MD, Ichise M: PET quantification of pancreatic VMAT 2 binding using (+) and (-) enantiomers of [18F]FP-DTBZ in baboons. Nucl Med Biol. 40(1): 60-64, 2013.
Farwell MD, Chong DJ, Iida Y, Bae SA, Easwaramoorthy B, Ichise M: Imaging P-glycoprotein function in rats using [(11)C]-N-desmethyl-loperamide. Ann Nucl Med. 27(7): 618-624, 2013.
back to top
Last updated: 02/01/2017
The Trustees of the University of Pennsylvania